Kyruus takes $30 million more for patient access
Just five months after closing a $42 million Series D funding round, Kyruus has raised a further $30 million. The investment comes from private equity firm Francisco Partners.
US
COVID-19 accelerates healthtech adoption
Cost pressures in US healthcare exacerbated by COVID-19 have accelerated adoption of tech to better serve patients and improve margins.
Digital transformation threatens data security at US healthcare organisations
Criminals target sensitive data left unencrypted after digital transformation initiatives
Recursion Pharmaceuticals $121 million Series C for AI drug discovery
Recursion Pharmceuticals has closed a $121 million Series C funding round, led by Scottish Mortgage Investment Trust, with participation from new and all prior institutional investors. The funds will be invested to continue building Recursion’s AI-enabled drug discovery platform, as well as to develop capabilities to accelerate new chemical entity chemistry and predict safety pharmacology. Recursion […]
BioPharma Ledger brings blockchain to clinical trials
ALTEN Calsoft Labs launches blockchain clinical trial platform in partnership with clinical research organisation Clinlogix
Belong.Life raises $14 million B round to build out C word solution
The social network for cancer will use the funds to expand its service and enter new markets through its patient engagement platform
Cala Health raises $50m for wearable tremor therapy
Cala Health, which develops bioelectrical therapies for chronic diseases, has closed a $50 million Series C financing round
MedCrypt raises $5.3 million as concerns for medtech cybersecurity grow
MedCrypt, a medical device cybersecurity software provider, has closed a Series A round of $5.3 million, led by Section 32, with participation from Eniac Ventures and Y Combinator. The funds will be used for sales and marketing, and for product development.
Ablacon raises $21.5 million for atrial fibrillation AI
Ablacon, which is developing an atrial fibrillation (AFib) mapping system, has closed a $21.5 million Series A funding round led by Ajax Health.
908 Devices raise $17.5 million Series E led by Northpond Ventures
908 Devices, a pioneer of analytical devices for chemical and biomolecular analysis, has raised a $17.5 million Series E financing round led by Northpond Ventures.